US Patent Issued to Alfasigma on Dec. 23 for "Pharmaceutical compositions comprising a JAK inhibitor" (California Inventors)

ALEXANDRIA, Va., Dec. 23 -- United States Patent no. 12,502,394, issued on Dec. 23, was assigned to Alfasigma S.p.A. (Bologna, Italy).

"Pharmaceutical compositions comprising a JAK inhibitor" was invented by David Alonzo (Foster City, Calif.), Bei Li (Foster City, Calif.) and Dimitrios Stefanidis (Saratoga, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Pharmaceutical compositions comprising filgotinib maleate Form I, further comprising citric acid, and characterized by an XRPD pattern substantially the same as shown in FIG. 1 and uses thereof are described herein."

The patent was filed on April 5, 2024, under Application No. 18/628,560.

*For further information, including images, charts and tables,...